Adenovirus-mediated expression of p33ING1b induces apoptosis and inhibits proliferation in gastric adenocarcinoma cells in vitro

Gastric Cancer

Volumn 15, Issue 4, 2012, Pages 355-362

  Lv, Yifei ^a   Purbey, Bibek Kumar ^a   Huang, Yanhua ^a   Li, Shuang ^a   Radha, Gurung ^a   Hao, Zhiming ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Gastric adenocarcinoma; P33ING1b; Proliferation

Indexed keywords

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; GREEN FLUORESCENT PROTEIN; PROTEIN P53; PROTEIN P53 INHIBITOR OF GROWTH 1B; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; EPITHELIUM CELL; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INHIBITOR OF GROWTH 1B GENE; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; STOMACH EPITHELIUM; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADENOCARCINOMA; ADENOVIRIDAE; APOPTOSIS; BENZOTHIAZOLES; CELL LINE, TUMOR; DOWN-REGULATION; EPITHELIAL CELLS; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NUCLEAR PROTEINS; RECOMBINANT PROTEINS; STOMACH NEOPLASMS; TOLUENE; TUMOR SUPPRESSOR PROTEINS;

EID: 84870347267     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-011-0123-4     Document Type: Article

References (31)

1. Ythier D, Larrieu D, Brambilla C, Brambilla E, Pedeux R. The new tumor suppressor genes ING: genomic structure and status in cancer. Int J Cancer. 2008;123: 1483-90.
2. Garkavtsev I, Demetrick D, Riabowol K. Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1). Cytogenet Cell Genet. 1997;76: 176-8.
3. Jäger D, Stockert E, Scanlan MJ, Güre AO, Jäger E, Knuth A, et al. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissuespecific ING1 transcripts and a homologue gene. Cancer Res. 1999;59: 6197-204.
4. Han X, Feng X, Rattner JB, Smith H, Bose P, Suzuki K, et al. Tethering by lamin A stabilizes and targets the ING1 tumour suppressor. Nat Cell Biol. 2008;10: 1333-40.
5. Gong W, Russell M, Suzuki K, Riabowol K. Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression. Mol Cell Biol. 2006;26: 2947-54.
6. Gong W, Suzuki K, Russell M, Riabowol K. Function of the ING family of PHD proteins in cancer. Int J Biochem Cell Biol. 2005;37: 1054-65.
7. Oki E, Maehara Y, Tokunaga E, Kakeji Y, Sugimachi K. Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer. Cancer Lett. 1999;147: 157-62.
8. Chen L, Matsubara N, Yoshino T, Nagasaka T, Hoshizima N, Shirakawa Y, et al. Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer. Cancer Res. 2001;61: 4345-9.
9. Tallen G, Riabowol K, Wolff JE. Expression of p33ING1 mRNA and chemosensitivity in brain tumour cells. Anticancer Res. 2003;23: 1631-5.
10. Toyama T, Iwase H, Watson P, Muzik H, Saettler E, Magliocco A, et al. Suppression of ING1 expression in sporadic breast cancer. Oncogene. 1999;18: 5187-93.
11. Nouman GS, Anderson JJ, Crosier S, Shrimankar J, Lunec J, Angus B. Downregulation of nuclear expression of the p33ING1b inhibitor of growth protein in invasive carcinoma of the breast. J Clin Pathol. 2003;56: 507-11.
12. Ito K, Kinjo K, Nakazato T, Ikeda Y, Kizaki M. Expression and sequence analyses of p33 (ING1) gene in myeloid leukemia. Am J Hematol. 2002;69: 141-3.
13. Kameyama K, Huang CL, Liu D, Masuya D, Nakashima T, Sumitomo S, et al. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients. Clin Cancer Res. 2003;9: 4926-34.
14. Ohgi T, Masaki T, Nakai S, Morishita A, Yukimasa S, Nagai M, et al. Expression of p33 (ING1) in hepatocellular carcinoma: relationships to tumour differentiation and cyclin E kinase activity. Scand J Gastroenterol. 2002;37: 1440-8.
15. Gunduz M, Ouchida M, Fukushima K, Hanafusa H, Etani T, Nishioka S, et al. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas. Cancer Res. 2000;60: 3143-6.
16. Ohmori M, Nagai M, Tasaka T, Koeffler HP, Toyama T, Riabowol K, et al. Decreased expression of p33ING1b mRNA in lymphoid malignancies. Am J Hematol. 1999;62: 118-9.
17. Nouman GS, Angus B, Lunec J, Crosier S, Lodge A, Anderson JJ. Comparative assessment expression of the inhibitor of growth 1 gene (ING1) in normal and neoplastic tissues. Hybrid Hybridomics. 2002;21: 1-10.
18. Shen DH, Chan KYK, Khoo US, Ngan HYS, Xue WC, Chiu PM, et al. Epigenetic and genetic alterations of p33ING1b in ovarian cancer. Carcinogenesis. 2005;26: 855-63.
19. Tallen G, Kaiser I, Krabbe S, Lass U, Hartmann C, Henze G. No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma. Int J Cancer. 2004;109: 476-9.
20. Garkavtsev I, Kazarov A, Gudkov A, Riabowol K. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat Genet. 1996;14: 415-20.
21. Shinoura N, Muramatsu Y, Nishimura M, Yoshida Y, Saito A, Yokoyama T, et al. Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas. Cancer Res. 1999;59: 5521-8.
22. Nouman GS, Anderson JJ, Mathers ME, Leonard N, Crosier S, Lunec J, Angus B. Nuclear to cytoplasmic compartment shift of the p33ING1b tumour suppressor protein is associated with malignancy in melanocytic lesions. Histopathology. 2002;40: 360-6.
23. Goeman F, Thormeyer D, Abad M, Serrano M, Schmidt O, Palmero I, et al. Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras. Mol Cell Biol. 2005;25: 422-31.
24. Garkavtsev I, Riabowol K. Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33(ING1) candidate tumor suppressor. Mol Cell Biol. 1997;17: 2014-9.
25. Tsang FC, Po LS, Leung KM, Lau A, Siu WY, Poon RY. ING1b decreases cell proliferation through p53-dependent and -independent mechanisms. FEBS Lett. 2003;553: 277-85.
26. Zhu Z, Luo Z, Li Y, Ni C, Li H, Zhu M. Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner. Hepatology. 2009;49: 504-12.
27. Garate M, Campos EI, Bush JA, Xiao H, Li G. Phosphorylation of the tumor suppressor p33(ING1b) at Ser-126 influences its protein stability and proliferation of melanoma cells. FASEB J. 2007;21: 3705-16.
28. Zhu Z, Lin J, Qu JH, Feitelson MA, Ni CR, Li FM, et al. Inhibitory effect of tumor suppressor p33ING1b and its synergy with p53 gene in hepatocellular carcinoma. World J Gastroenterol. 2005;11: 1903-9.
29. Zhu JJ, Li FB, Zhu XF, Liao WM. The p33ING1b tumor suppressor cooperates with p53 to induce apoptosis in response to etoposide in human osteosarcoma cells. Life Sci. 2006;78: 1469-77.
30. Cheung KJ Jr, Bush JA, Jia W, Li G. Expression of the novel tumour suppressor p33(ING1) is independent of p53. Br J Cancer. 2000;83: 1468-72.
31. Coles AH, Liang H, Zhu Z, Marfella CGA, Kang J, Imbalzano AN, et al. Deletion of p37Ing1 in mice reveals a p53-independent role for Ing1 in the suppression of cell proliferation, apoptosis, and tumorigenesis. Cancer Res. 2007;67: 2054-61.